Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (GB:0A87)
LSE:0A87
RESEARCH TOOLSreports
Holding GB:0A87?
Track your performance easily
0A87 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.59 - $15.07
Previous Close$14.37
Volume63.00
Average Volume (3M)1.10K
Market Cap
$45.27B
Enterprise Value$74.69B
Total Cash (Recent Filing)¥457.80B
Total Debt (Recent Filing)¥4.84T
Price to Earnings (P/E)46.1
Beta0.29
Next Earnings
Oct 31, 2024EPS Estimate
$0.09Last Dividend Ex-Date
Mar 27, 2024Dividend Yield3.93%
Share Statistics
EPS (TTM)0.31
Shares Outstanding3,138,026,928
10 Day Avg. Volume1,629
30 Day Avg. Volume1,099
Standard Deviation0.06
R-Squared0.08
Alpha-0.00371
Financial Highlights & Ratios
Price to Book (P/B)0.00600
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$14.80Price Target Upside3.03% Upside
Rating ConsensusHold
Number of Analyst Covering1
Takeda Pharmaceutical Company News
PremiumCompany Announcements
Takeda Pharmaceutical Announces Subsidiary Merger
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.43% Mutual Funds
0.02% Other Institutional Investors
99.35% Public Companies and
Individual Investors
0A87 FAQ
What was Takeda Pharmaceutical Company’s price range in the past 12 months?
Takeda Pharmaceutical Company lowest share price was $12.59 and its highest was $15.07 in the past 12 months.
What is Takeda Pharmaceutical Company’s market cap?
Currently, no data Available
When is Takeda Pharmaceutical Company’s upcoming earnings report date?
Takeda Pharmaceutical Company’s upcoming earnings report date is Oct 31, 2024 which is in 18 days.
How were Takeda Pharmaceutical Company’s earnings last quarter?
Takeda Pharmaceutical Company released its earnings results on Jul 31, 2024. The company reported $0.203 earnings per share for the quarter, beating the consensus estimate of $0.123 by $0.08.
Is Takeda Pharmaceutical Company overvalued?
According to Wall Street analysts Takeda Pharmaceutical Company’s price is currently Undervalued.
Does Takeda Pharmaceutical Company pay dividends?
Takeda Pharmaceutical Company pays a Semiannually dividend of $0.3 which represents an annual dividend yield of 3.93%. See more information on Takeda Pharmaceutical Company dividends here
What is Takeda Pharmaceutical Company’s EPS estimate?
Takeda Pharmaceutical Company’s EPS estimate is $0.09.
How many shares outstanding does Takeda Pharmaceutical Company have?
Takeda Pharmaceutical Company has 3,181,875,200 shares outstanding.
What happened to Takeda Pharmaceutical Company’s price movement after its last earnings report?
Takeda Pharmaceutical Company reported an EPS of $0.203 in its last earnings report, beating expectations of $0.123. Following the earnings report the stock price went up 4.138%.
Which hedge fund is a major shareholder of Takeda Pharmaceutical Company?
Among the largest hedge funds holding Takeda Pharmaceutical Company’s share is Brandes Investment Partners LP. It holds Takeda Pharmaceutical Company’s shares valued at 34M.
---
Takeda Pharmaceutical Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.80 (3.03% Upside)
$14.80 (3.03% Upside)
Blogger Sentiment
Bullish
GB:0A87 Sentiment 66%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.65%
12-Months-Change
Fundamentals
Return on Equity
2.02%
Trailing 12-Months
Asset Growth
-1.43%
Trailing 12-Months
Company Description
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is engaged in the research and development, manufacturing, marketing, and importing and exporting of pharmaceutical drugs and other healthcare products. The company offers pharmaceutical products in the areas of oncology, neuroscience, gastroenterology, and rare diseases.
---
0A87 Company Deck
---
0A87 Earnings Call
Q1 2024
0:00 / 0:00
---
0A87 Stock 12 Month Forecast
Average Price Target
$14.80
▲(3.03% Upside)
Technical Analysis
Best Analysts Covering 0A87
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-8.90%
reiterated a buy rating 10 months ago
Copying Koichi Mamegano's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -8.90% per trade.
---